Cheongin Haewoohwan
- Manufacturer
- Entechbio Co., Ltd
- Effective date
- 2011-02-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:27:17
Label at a glance#
ProductCheongin Haewoohwan
Active ingredientLACTIC ACID
Label structure8 sections
Label contents#
Full prescribing information#
active ingredient: lactic acid (lactobacillus casei, lactobacillus bifidus)
INACTIVE INGREDIENT SECTION
inactive ingredient: GLYCINE, HOVENIA DULCIS FRUIT, PUERARIA MONTANA VAR. LOBATA ROOT, GLYCYRRHIZA URALENSIS
OTC - PURPOSE SECTION
to prevent high blood pressure, arteriosclerosis
to mitigate constipation
to mitigate constipation
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
take 1 packet with enough water after meal
WARNINGS SECTION
do not take if you have an idiosyncratic of allergic reaction symptom
do not take over 3 packet a day
do not take over 3 packet a day
DOSAGE & ADMINISTRATION SECTION
take continuously even if you feel improvement of physical constitution
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LACTIC ACID, UNSPECIFIED FORM Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20220121 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75863-3001-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c7f1-8e05-e053-dbdaa90a074a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75863-3001-1 | Cheongin Haewoohwan | 5 g in 1 PACKET | PELLET | 5 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 75863-3001 | CHEONGIN HAEWOOHWAN (LACTIC ACID) PELLET [ENTECHBIO CO., LTD] | 1 | Legacy NDC, 1 package rows | 20110222_fbc0ad65-64d4-41cc-868b-96e992d32eae.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LACTIC ACID | ACTIVE INGREDIENT | 33X04XA5AT | 1 | |
| LACTIC ACID | ACTIVE MOIETY | 33X04XA5AT | 1 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 1 | |
| GLYCYRRHIZA URALENSIS | INACTIVE INGREDIENT | 42B5YD8F0K | 1 | |
| HOVENIA DULCIS FRUIT | INACTIVE INGREDIENT | 18F22L82RE | 1 | |
| PUERARIA MONTANA VAR. LOBATA ROOT | INACTIVE INGREDIENT | PET93F4I3C | 1 |
Products#
Every source-derived product name is available through these pages.
- Cheongin Haewoohwan
- lactic acid
- GLYCINE
- HOVENIA DULCIS FRUIT
- PUERARIA MONTANA VAR. LOBATA ROOT
- GLYCYRRHIZA URALENSIS
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 75863-3001 | 75863-3001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTIC ACID | 33X04XA5AT | ACTIB |
| GLYCINE | TE7660XO1C | IACT |
| HOVENIA DULCIS FRUIT | 18F22L82RE | IACT |
| PUERARIA MONTANA VAR. LOBATA ROOT | PET93F4I3C | IACT |
| GLYCYRRHIZA URALENSIS | 42B5YD8F0K | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | 0.5 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3.76 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 10 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | CAPSULE, DELAYED RELEASE / ORAL | 50 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | POWDER, FOR SUSPENSION / ORAL | 400 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION / INTRAMUSCULAR | 68 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | PASTE, DENTIFRICE / DENTAL | 0.34 %w/w | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, SOLUTION / INTRAVENOUS | 0.42 %w/v | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 40 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | SOLUTION / ORAL | 50 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | POWDER, FOR SOLUTION / ORAL | 0.09 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION / INTRAVENOUS | 200 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 0.38 %w/v | ||
| GLYCINE | GLYCINE | TE7660XO1C | CAPSULE / ORAL | 62 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.5 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 200 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET, ORALLY DISINTEGRATING / ORAL | 60 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET / ORAL | 163.31 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET, CHEWABLE / ORAL | 267 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b9ee848e-2150-4024-8d9f-0c48744f8ffb | fbc0ad65-64d4-41cc-868b-96e992d32eae | 2011-02-18 | Warnings | b9ee848e-2150-4024-8d9f-0c48744f8ffb fbc0ad65-64d4-41cc-868b-96e992d32eae |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
